181 related articles for article (PubMed ID: 21557945)
21. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB
Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
23. Expression of macrophage-colony stimulating factor in normal and inflammatory bowel disease intestine.
Klebl FH; Olsen JE; Jain S; Doe WF
J Pathol; 2001 Dec; 195(5):609-15. PubMed ID: 11745698
[TBL] [Abstract][Full Text] [Related]
24. Increased circulating circular RNA_103516 is a novel biomarker for inflammatory bowel disease in adult patients.
Ye YL; Yin J; Hu T; Zhang LP; Wu LY; Pang Z
World J Gastroenterol; 2019 Nov; 25(41):6273-6288. PubMed ID: 31749597
[TBL] [Abstract][Full Text] [Related]
25. The value of mRNA expression of S100A8 and S100A9 as blood-based biomarkers of inflammatory bowel disease.
Azramezani Kopi T; Amini Kadijani A; Parsian H; Shahrokh S; Asadzadeh Aghdaei H; Mirzaei A; Balaii H; Zali MR
Arab J Gastroenterol; 2019 Sep; 20(3):135-140. PubMed ID: 31563476
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP.
Zhernakova A; Festen EM; Franke L; Trynka G; van Diemen CC; Monsuur AJ; Bevova M; Nijmeijer RM; van 't Slot R; Heijmans R; Boezen HM; van Heel DA; van Bodegraven AA; Stokkers PC; Wijmenga C; Crusius JB; Weersma RK
Am J Hum Genet; 2008 May; 82(5):1202-10. PubMed ID: 18439550
[TBL] [Abstract][Full Text] [Related]
27. Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.
Linares PM; Algaba A; Urzainqui A; Guijarro-Rojas M; González-Tajuelo R; Garrido J; Chaparro M; Gisbert JP; Bermejo F; Guerra I; Castellano V; Fernández-Contreras ME
Dig Dis Sci; 2017 Oct; 62(10):2744-2754. PubMed ID: 28823012
[TBL] [Abstract][Full Text] [Related]
28. Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Mortha A; Remark R; Del Valle DM; Chuang LS; Chai Z; Alves I; Azevedo C; Gaifem J; Martin J; Petralia F; Tuballes K; Barcessat V; Tai SL; Huang HH; Laface I; Jerez YA; Boschetti G; Villaverde N; Wang MD; Korie UM; Murray J; Choung RS; Sato T; Laird RM; Plevy S; Rahman A; Torres J; Porter C; Riddle MS; Kenigsberg E; Pinho SS; Cho JH; Merad M; Colombel JF; Gnjatic S
Gastroenterology; 2022 Sep; 163(3):659-670. PubMed ID: 35623454
[TBL] [Abstract][Full Text] [Related]
29. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
30. Genetics of inflammatory bowel disease from multifactorial to monogenic forms.
Bianco AM; Girardelli M; Tommasini A
World J Gastroenterol; 2015 Nov; 21(43):12296-310. PubMed ID: 26604638
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of CCL20 in human inflammatory bowel disease.
Kaser A; Ludwiczek O; Holzmann S; Moschen AR; Weiss G; Enrich B; Graziadei I; Dunzendorfer S; Wiedermann CJ; Mürzl E; Grasl E; Jasarevic Z; Romani N; Offner FA; Tilg H
J Clin Immunol; 2004 Jan; 24(1):74-85. PubMed ID: 14997037
[TBL] [Abstract][Full Text] [Related]
32. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
[TBL] [Abstract][Full Text] [Related]
33. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
34. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
35. High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease.
Di Narzo AF; Brodmerkel C; Telesco SE; Argmann C; Peters LA; Li K; Kidd B; Dudley J; Cho J; Schadt EE; Kasarskis A; Dobrin R; Hao K
J Crohns Colitis; 2019 Mar; 13(4):462-471. PubMed ID: 30445421
[TBL] [Abstract][Full Text] [Related]
36. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage.
Joshi PC; Applewhite L; Ritzenthaler JD; Roman J; Fernandez AL; Eaton DC; Brown LA; Guidot DM
J Immunol; 2005 Nov; 175(10):6837-45. PubMed ID: 16272341
[TBL] [Abstract][Full Text] [Related]
37. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
[TBL] [Abstract][Full Text] [Related]
38. Impact of Low Immunoglobulin G Levels on Disease Outcomes in Patients with Inflammatory Bowel Diseases.
Horton N; Wu X; Philpott J; Garber A; Achkar JP; Brzezinski A; Lashner BA; Shen B
Dig Dis Sci; 2016 Nov; 61(11):3270-3277. PubMed ID: 27619393
[TBL] [Abstract][Full Text] [Related]
39. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
Xu Y; Xu F; Li W; Li M; Dong S; Zhang Y; Norman GL; Zhao Q; Liu L
Scand J Gastroenterol; 2020 Jul; 55(7):806-813. PubMed ID: 32568566
[No Abstract] [Full Text] [Related]
40. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
